131 related articles for article (PubMed ID: 37897912)
21. PDTAC: Targeted Photodegradation of GPX4 Triggers Ferroptosis and Potent Antitumor Immunity.
Liu S; Zhao X; Shui S; Wang B; Cui Y; Dong S; Yuwen T; Liu G
J Med Chem; 2022 Sep; 65(18):12176-12187. PubMed ID: 36066386
[TBL] [Abstract][Full Text] [Related]
22. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
23. Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer.
Hung CL; Liu HH; Fu CW; Yeh HH; Hu TL; Kuo ZK; Lin YC; Jhang MR; Hwang CS; Hsu HC; Kung HJ; Wang LY
EBioMedicine; 2023 Apr; 90():104500. PubMed ID: 36893587
[TBL] [Abstract][Full Text] [Related]
24. Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis.
Liu S; Zhang HL; Li J; Ye ZP; Du T; Li LC; Guo YQ; Yang D; Li ZL; Cao JH; Hu BX; Chen YH; Feng GK; Li ZM; Deng R; Huang JJ; Zhu XF
Redox Biol; 2023 Jun; 62():102677. PubMed ID: 36989572
[TBL] [Abstract][Full Text] [Related]
25. Enhanced Tumor Targeting and Penetration of Proteolysis-Targeting Chimeras through iRGD Peptide Conjugation: A Strategy for Precise Protein Degradation in Breast Cancer.
He S; Fang Y; Wu M; Zhang P; Gao F; Hu H; Sheng C; Dong G
J Med Chem; 2023 Dec; 66(24):16828-16842. PubMed ID: 38055861
[TBL] [Abstract][Full Text] [Related]
26. Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells.
Lama R; Galster SL; Xu C; Davison LW; Chemler SR; Wang X
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431769
[TBL] [Abstract][Full Text] [Related]
27. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis.
Li H; Liu W; Zhang X; Wu F; Sun D; Wang Z
Biochem Biophys Res Commun; 2021 Dec; 585():111-116. PubMed ID: 34800882
[TBL] [Abstract][Full Text] [Related]
28. Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression.
Wang K; Dai X; Yu A; Feng C; Liu K; Huang L
J Exp Clin Cancer Res; 2022 Sep; 41(1):289. PubMed ID: 36171633
[TBL] [Abstract][Full Text] [Related]
29. An MDM2 degrader for treatment of acute leukemias.
Marcellino BK; Yang X; Ümit Kaniskan H; Brady C; Chen H; Chen K; Qiu X; Clementelli C; Herschbein L; Li Z; Elghaity-Beckley S; Arandela J; Kelly B; Hoffman R; Liu J; Xiong Y; Jin J; Shih AH
Leukemia; 2023 Feb; 37(2):370-378. PubMed ID: 36309559
[TBL] [Abstract][Full Text] [Related]
30. Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis.
Liu X; Zhong S; Qiu K; Chen X; Wu W; Zheng J; Liu Y; Wu H; Fan S; Nie D; Wang X; Yu Z; Liao Z; Zhong M; Li Y; Zeng C
Exp Hematol Oncol; 2023 May; 12(1):47. PubMed ID: 37198609
[TBL] [Abstract][Full Text] [Related]
31. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.
Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J
Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793
[TBL] [Abstract][Full Text] [Related]
32. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis.
Golbashirzadeh M; Heidari HR; Aghamolayi AA; Fattahi Y; Talebi M; Khosroushahi AY
Med Oncol; 2023 Aug; 40(10):279. PubMed ID: 37632628
[TBL] [Abstract][Full Text] [Related]
33. Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression.
Li Y; Yang J; Aguilar A; McEachern D; Przybranowski S; Liu L; Yang CY; Wang M; Han X; Wang S
J Med Chem; 2019 Jan; 62(2):448-466. PubMed ID: 30525597
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol drives ferroptosis of acute myeloid leukemia cells through Hsa-miR-335-5p/NFS1/ GPX4 pathway in a ROS-dependent manner.
Liu J; Gao W; Sheng Y; Sun J; Wen D
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):131-137. PubMed ID: 37715395
[TBL] [Abstract][Full Text] [Related]
35. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
Probst L; Dächert J; Schenk B; Fulda S
Biochem Pharmacol; 2017 Sep; 140():41-52. PubMed ID: 28595877
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia.
Lalonde ME; Sasseville M; Gélinas AM; Milanese JS; Béland K; Drouin S; Haddad E; Marcotte R
Haematologica; 2023 Feb; 108(2):382-393. PubMed ID: 36134452
[TBL] [Abstract][Full Text] [Related]
37. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells.
Wang H; Wang C; Li B; Zheng C; Liu G; Liu Z; Zhang L; Xu P
Eur J Med Chem; 2023 Jun; 254():115343. PubMed ID: 37087895
[TBL] [Abstract][Full Text] [Related]
38. Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis.
Chen M; Shi Z; Sun Y; Ning H; Gu X; Zhang L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675129
[TBL] [Abstract][Full Text] [Related]
39. Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Porazzi P; De Dominici M; Salvino J; Calabretta B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573335
[TBL] [Abstract][Full Text] [Related]
40. Diaryl ether derivative inhibits GPX4 expression levels to induce ferroptosis in thyroid cancer cells.
Pamarthy D; Behera SK; Swain S; Yadav S; Suresh S; Jain N; Bhadra MP
Drug Dev Res; 2023 Aug; 84(5):861-887. PubMed ID: 37070554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
